Literature DB >> 9362432

Overview of bisphosphonates.

M J Rogers1, D J Watts, R G Russell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9362432     DOI： 10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  64 in total

Review 1.  Paget's disease of bone: a disease of the osteoclast.

Authors:  S V Reddy; N Kurihara; C Menaa; G D Roodman
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.

Authors:  Yuwei Wang; Alexandra Panasiuk; David W Grainger
Journal:  Mol Pharm       Date:  2011-01-21       Impact factor: 4.939

3.  Farnesyl diphosphate synthase is a cytosolic enzyme in Leishmania major promastigotes and its overexpression confers resistance to risedronate.

Authors:  Aurora Ortiz-Gómez; Carmen Jiménez; Antonio M Estévez; Juana Carrero-Lérida; Luis M Ruiz-Pérez; Dolores González-Pacanowska
Journal:  Eukaryot Cell       Date:  2006-07

Review 4.  [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].

Authors:  K Heine; J M Wolff
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

Review 5.  Bisphosphonates and other bone agents for breast cancer.

Authors:  Brent O'Carrigan; Matthew Hf Wong; Melina L Willson; Martin R Stockler; Nick Pavlakis; Annabel Goodwin
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

Review 6.  Spinal cord compression in cancer patients: review of diagnosis and treatment.

Authors:  Marta Penas-Prado; Monica E Loghin
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

7.  Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

Authors:  Meral Günaldi; Cigdem Usul Afsar; Berna Bozkurt Duman; Ismail Oguz Kara; Ufuk Tatli; Berksoy Sahin
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

8.  Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.

Authors:  C Walter; M O Klein; A Pabst; B Al-Nawas; H Duschner; T Ziebart
Journal:  Clin Oral Investig       Date:  2009-03-18       Impact factor: 3.573

9.  Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.

Authors:  Shinya Kimura; Junya Kuroda; Hidekazu Segawa; Kiyoshi Sato; Masaki Nogawa; Takeshi Yuasa; Oliver G Ottmann; Taira Maekawa
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

10.  Correlation of high-resolution X-ray micro-computed tomography with bioluminescence imaging of multiple myeloma growth in a xenograft mouse model.

Authors:  Andrei A Postnov; Henk Rozemuller; Viviene Verwey; Henk Lokhorst; Nora De Clerck; Anton C Martens
Journal:  Calcif Tissue Int       Date:  2009-10-09       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.